EUROAPI Hungary Ltd.
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products, Lessors of Real Property, Not Elsewhere Classified, Land Subdividers and Developers, Except Cemeteries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about EUROAPI Hungary Ltd.
Live alerts from global media, monitored by Business Radar
2023-01-31 (tradingsat.com)
Euroapi: The Euroapi plant in Budapest restarts its production of hormones which was suspended
(BFM Bourse) - The active ingredient specialist announces a gradual restart of the manufacture of certain hormones on its site in Hungary before ...
Read more
(chemanalyst.com)
EUROAPI to Ramp Up Production of Prostaglandin APIs in January 2023
EUROAPI, the largest prostaglandin API producer in the world, has built and successfully implemented a comprehensive remediation plan.
Read more
(endpts.com)
EuroAPI halts production at Italian site as quality control issues due to 'potential' misconduct come to light
EuroAPI is pausing all production at its site in Brindisi, Italy, causing Sanofi's API spinoff to delay its 2024 guidance until the second ...
Read more